Impact of splenectomy for lymph node dissection on long-term surgical outcome in gastric cancer

被引:22
作者
Lee, KY
Noh, SH
Hyung, WJ
Lee, JH
Lah, KH
Choi, SH
Min, JS
机构
[1] Yonsei Univ, Coll Med, Dept Surg, Seoul, South Korea
[2] Yonsei Univ, Coll Med, Canc Metastasis Res Ctr, Seoul, South Korea
关键词
splenectomy; lymph node dissection; long-term outcome; gastric cancer;
D O I
10.1245/aso.2001.8.5.402
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: In the treatment of gastric cancer, splenectomy is performed for effective lymph. node dissection around the splenic artery and splenic hilum. The purpose of this study was to clarify the long-term outcome of splenectomy in the treatment of gastric cancer. Methods: The effect of splenectomy on recurrence and prognosis was examined in a retrospective analysis of 665 patients who had undergone curative total gastrectomy for gastric carcinoma from 1987 to 1996. The risk factors associated with recurrence and prognosis were investigated by univariate and multivariate analysis. Results: The splenectomy group showed more advanced lesions and a higher recurrence rate than the spleen-preserved group. However, after adjusting for the TNM (tumor, node, metastasis) stage, there was no significant difference in recurrence rate and pattern between the two groups. Logistic regression analysis revealed that gross type, serosal invasion, and nodal metastasis were independent risk factors for recurrence while splenectomy was not. When comparing patients with the same TNM (tumor, node, metastasis) stages, no significant difference in the 5-year survival rates was apparent. Multivariate analysis demonstrated that age, serosal invasion, and nodal metastasis were independent prognostic factors whereas splenectomy was not. Conclusions: These data suggest that splenectomy for lymph node dissection in gastric cancer is not effective regarding long-term patient prognosis.
引用
收藏
页码:402 / 406
页数:5
相关论文
共 20 条
[1]  
[Anonymous], INT UNION CANC TNM C
[2]   Extended lymph-node dissection for gastric cancer [J].
Bonenkamp, JJ ;
Hermans, J ;
Sasako, M ;
van de Velde, CJH .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (12) :908-914
[3]  
BRADY MS, 1991, ARCH SURG-CHICAGO, V126, P359
[4]   Lymph-node dissection for gastric cancer [J].
Brennan, MF .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (12) :956-958
[5]   Postoperative morbidity and mortality after D-1 and D-2 resections for gastric cancer: Preliminary results of the MRC randomised controlled surgical trial [J].
Cuschieri, A ;
Fayers, P ;
Fielding, J ;
Craven, J ;
Bancewicz, J ;
Joypaul, V ;
Cook, P .
LANCET, 1996, 347 (9007) :995-999
[6]   RESULTS OF SURGERY ON 6589 GASTRIC-CANCER PATIENTS AND IMMUNOCHEMOSURGERY AS THE BEST TREATMENT OF ADVANCED GASTRIC-CANCER [J].
KIM, JP ;
KWON, CJ ;
OH, ST ;
YANG, HK ;
COHN, I ;
WANEBO, HJ .
ANNALS OF SURGERY, 1992, 216 (03) :269-279
[7]   No survival benefit from combined pancreaticosplenectomy and total gastrectomy for gastric cancer [J].
Kitamura, K ;
Nishida, S ;
Ichikawa, D ;
Taniguchi, H ;
Hagiwara, A ;
Yamaguchi, T ;
Sawai, K .
BRITISH JOURNAL OF SURGERY, 1999, 86 (01) :119-122
[8]  
MAEHARA Y, 1991, CANCER, V67, P3006, DOI 10.1002/1097-0142(19910615)67:12<3006::AID-CNCR2820671213>3.0.CO
[9]  
2-V
[10]   LYMPH-NODE METASTASES OF GASTRIC-CANCER - GENERAL PATTERN IN 1931 PATIENTS [J].
MARUYAMA, K ;
GUNVEN, P ;
OKABAYASHI, K ;
SASAKO, M ;
KINOSHITA, T .
ANNALS OF SURGERY, 1989, 210 (05) :596-602